|
|
|
Volumn 39, Issue 7, 2014, Pages
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBIGLUTIDE;
ANAPLASTIC LYMPHOMA KINASE;
CERITINIB;
GLUCAGON LIKE PEPTIDE 1;
RAMUCIRUMAB;
TANZEUM;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR 2;
ZYKADIA;
ABDOMINAL PAIN;
ALLERGIC REACTION;
ARTERIAL THROMBOEMBOLISM;
BLEEDING;
BRADYCARDIA;
CLINICAL TRIAL (TOPIC);
DIARRHEA;
DIGESTIVE SYSTEM PERFORATION;
DRUG APPROVAL;
DRUG MECHANISM;
END STAGE RENAL DISEASE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPOGLYCEMIA;
INFUSION RELATED REACTION;
INTERSTITIAL LUNG DISEASE;
LIVER TOXICITY;
LUNG NON SMALL CELL CANCER;
NAUSEA AND VOMITING;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PANCREATITIS;
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME;
QT PROLONGATION;
STOMACH CANCER;
WOUND HEALING IMPAIRMENT;
|
|
EID: 84904430503
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
